Experimental study on the role of endotoxin in the development of hepatopulmonary syndrome

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

401

HTML

2562

Figures (1-1)

218

Tables (1-10)

195

Sum=3376

Jan 28, 2005 (publication date) through Nov 28, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Jan 28, 2005; 11(4): 567-572
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.567

Table 7 Levels of plasma ET-1 and lung homogenates in rats with cirrhosis (mean±SD, n = 6).

Group	Plasma (ng/L)	Lung homogenate (ng/kg protein)
Normal control	92.0083±7.7498	163.3167±30.8496
Normal+endotoxin	391.3117±74.8649^a	290.4733±78.3474^e
Cirrhosis	224.0433±8.1965^a	303.3683±44.6253^e
Cirrhosis+endotoxin	377.2550±28.9485^a	385.5517±143.1575^e
Cirrhosis+endotoxin+glycine	271.2217±43.7350^a^c	361.2283±71.4878^e^g

^aP<0.05 vs normal control group;

^cP<0.05 vs cirrhosis+endotoxin group;

^eP<0.05 vs normal control group;

^gP<0.05 vs cirrhosis +endotoxin group.

Citation: Zhang HY, Han DW, Wang XG, Zhao YC, Zhou X, Zhao HZ. Experimental study on the role of endotoxin in the development of hepatopulmonary syndrome. World J Gastroenterol 2005; 11(4): 567-572
URL: https://www.wjgnet.com/1007-9327/full/v11/i4/567.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i4.567